BayMedica

Biotechnology ResearchNevada, United States2-10 Employees

BayMedica is a biotechnology entity focused on producing rare cannabinoids through synthetic biology and pharmaceutical chemistry. As a division of InMed Pharmaceuticals, it operates within the biotechnology research sector to develop a scalable, proprietary platform aimed at delivering high-quality, rare cannabinoids for consumer applications and cannabinoid-derived pharmaceutical compounds. The company emphasizes high purity and controlled production processes to support its product portfolio. Based in Incline Village, Nevada, it engages with a market that spans consumer wellness products and pharmaceutical development, leveraging its specialized capabilities to address quality and consistency in rare cannabinoid supply.

BayMedica targets customers in both consumer and pharmaceutical contexts that require rare cannabinoids and related chemical entities. Its work aligns with a broader industry focus on biotechnology-enabled cannabinoid production, positioning the company as a specialized provider within a landscape of other cannabinoid-focused firms. A recent development noted is the launch of a delta 9-dominant tetrahydrocannabivarin, highlighting ongoing product advancement and expansion within its rare cannabinoid lineup. The company operates as a small-scale biotechnology player with proximity to InMed’s broader corporate structure and strategic objectives.

Sign up for free to view info

Email Format Employee directory